Protein First: Whey Protein Administration Strategy in Critically ill Patients

Tomy Suharsoyo, Erlangga Prasamya

Abstract

Background: Critically ill patients in the intensive care unit (ICU) frequently develop hypercatabolic states associated with progressive muscle wasting and immune dysfunction. Meeting adequate protein targets remains a persistent challenge in standard ICU nutrition practice.

Methods: A narrative review of the literature was conducted by searching PubMed, MEDLINE, and Google Scholar using the keywords “whey protein,” “critically ill,” “ICU nutrition,” “protein-first strategy,” “enteral nutrition,” and related terms. Articles published between 2015 and 2025 were prioritized, and foundational earlier studies were included where relevant. Randomized controlled trials, systematic reviews, meta-analyses, observational studies, consensus guidelines, and mechanistic studies were included. Articles without full-text availability or not relevant to critical care nutrition were excluded.

Results: Whey protein is biologically characterized by rapid absorption, a rich essential amino acid profile, and a high leucine content that may activate the mTORC1 pathway to stimulate muscle protein synthesis. Whey protein–based enteral formulas have been shown in selected studies to facilitate achievement of recommended protein targets (1.2–2.5 g/kg/day) with acceptable gastrointestinal tolerance. Some evidence suggests potential benefits in nitrogen balance and inflammatory markers; however, evidence for consistent improvement in hard clinical outcomes—including mortality, ventilator duration, and ICU length of stay—across the general critically ill population remains limited. Most supportive studies are small, single-center, or focused on specific subpopulations, and several are feasibility assessments rather than outcome trials.

Conclusion: Whey protein is a biologically plausible and practically useful component of individualized ICU nutrition. A “Protein First” approach using whey-based formulas may assist in meeting recommended protein targets; however, current evidence does not support claims of universal outcome benefit. Individualized dosing—with particular caution in patients with renal or hepatic impairment—remains essential.

 

 

Keywords

Critically ill; Intensive care unit; High-Protein Enteral Nutrition; Protein First; Whey protein

Full Text:

PDF

References

  1. Tedeschi-Jockers F, Reinhold S, Hollinger A, et al. A new high protein-to-energy enteral formula with a whey protein hydrolysate to achieve protein targets in critically ill patients: a prospective observational tolerability study. Eur J Clin Nutr. 2022;76(3):419–427.
  2. Hill A, Elke G, Weimann A. Nutrition in the intensive care unit—a narrative review. Nutrients. 2021;13(8):2657.
  3. Cava E, Padua E, Campaci D, et al. Investigating the health implications of whey protein consumption: a narrative review of risks, adverse effects, and associated health issues. Healthcare (Basel). 2024;12(2):246.
  4. Moro T, Brightwell CR, Velarde B, et al. Whey protein hydrolysate increases amino acid uptake, mTORC1 signaling, and protein synthesis in skeletal muscle of healthy young men in a randomized crossover trial. J Nutr. 2019;149(7):1149–1158.
  5. Wolfe RR. Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? J Int Soc Sports Nutr. 2017;14(1):30.
  6. Tian F, van Zanten A, Liu G, et al. Feasibility of whey protein powder supplementation in patients who are neurocritically ill: a post hoc analysis of a pilot randomized controlled trial.Nutr Clin Pract. 2025;40(1):205–213.
  7. Hashemilar M, Khalili M, Rezaeimanesh N, et al. Effect of whey protein supplementation on inflammatory and antioxidant markers, and clinical prognosis in acute ischemic stroke (TNS Trial): a randomized, double blind, controlled, clinical trial. Adv Pharm Bull. 2020;10(1):135–140.
  8. Lee ZY, Yap CSL, Hasan MS, et al. The effect of higher versus lower protein delivery in critically ill patients: a systematic review and meta-analysis of randomized controlled trials. Crit Care. 2021;25(1):188.
  9. Marik PE. Feeding critically ill patients the right ‘whey’: thinking outside of the box. A personal view. Ann Intensive Care. 2015;5(1):11.
  10. Blaauw L, Schoonees A, Robertson N, Visser J. The impact of guideline recommended protein intake on mortality and length of intensive care unit and hospital stay in critically ill adults: a systematic review. Clin Nutr ESPEN. 2024;61:356–368.
  11. Hauschild DB, Oliveira LDA, Farias MS, et al. Enteral protein supplementation in critically ill children: a randomized controlled pilot and feasibility study. J Parenter Enter Nutr. 2019;43(2):281–289.
  12. Al-Dorzi HM, Arabi YM. Early administration of high protein for critically ill patients with acute kidney injury? Crit Care. 2023;27(1):45.
  13. Reinhold S, Yeginsoy D, Hollinger A, et al. Protein delivery in intermittent and continuous enteral nutrition with a protein-rich formula in critically ill patients. Trials. 2020;21(1):576.
  14. Scarcella M, Scarpellini E, Ascani A, et al. Effect of whey proteins on malnutrition and extubating time of critically ill COVID-19 patients. Nutrients. 2022;14(3):536.
  15. Summers MJ, Chapple L, Bellomo R, et al. Study protocol for TARGET protein: the effect of augmented administration of enteral protein to critically ill adults on clinical outcomes. Crit Care Resusc. 2023;25(3):147–154.

DOI: https://doi.org/10.20961/soja.v6i1.116549

Refbacks

  • There are currently no refbacks.